Small cell lung cancer · 6 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
CCDE and RT Variant #01 | — | R 2 568 | — | — | — | — | — | — |
Carboplatin, Etoposide, RT Variant #01 | — | R 2 277 | 21d | — | — | — | — | — |
Cyclophosphamide, Methotrexate, RT Variant #01 | — | R 1 792 | 77d | — | — | — | — | — |
CEV and RT Variant #01 | — | R 1 489 | 21d | — | — | — | — | — |
CAV and RT Variant #01 | — | R 760 | 21d | — | — | — | — | — |
Cisplatin, Etoposide, RT Partial | — | — | — | — | — | — | — | — |
6 of 6 regimens shown